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ducted. The study population included CB patients aged40 with2 years contin-
uous enrollment in the HIRD, 1 inpatient (INPT) admission/emergency
department (ED) visit or 2 outpatient visits with CB (ICD-9-CM 491.xx) during the
period from January 1, 2004 to May 31, 2011, and 2 pharmacy fills for COPD med-
ications (the first fill served as the index date). CB patients were followed for 1 year
to collect all-cause and COPD-related (ICD-9 codes: 491.xx, 492.xx, 496.xx) health
care resource utilization (HCRU) and costs. Generalized Linear Models (GLM) with
gamma distribution and log link function were utilized to identify HCRU cost
predictors. RESULTS: A total of 17,382 treated CB patients met inclusion/exclusion
criteria (50.6% female, mean age 66.711.4 years). During follow-up year, themean
number of COPD maintenance medication fills was 7.66.3; all-cause HCRU was:
39%had 1 INPT, 26.6% had 1 ED visits, and 98.4% had 1 office visits; andmean
total all-cause HCRU cost was $25,747 $51,105. COPD-related HCRU was: 32.6%
had  1 INPT, 12.9% had  1 ED visits, and 81.8% had 1 office visits; mean total
COPD-related HCRU cost was $12,609$36,801. GLM models showed that baseline
incidence of COPD exacerbations was a significant predictor of both all-cause
(0.0924, p0.0001) and COPD-related (0.1862, p0.0001) HCRU costs during
follow-up. Other significant predictors of follow-up COPD-related costs included
Deyo-Charlson Index (0.1370, p0.0001), female gender ( -0.1280, p0.0001),
and age (0.0084, p0.0001). CONCLUSIONS: HCRU and costs among CB patients
treated with COPDmaintenance medications were considerable during follow-up.
New medications and disease management interventions aiming to reduce HCRU
and costs among CB patients warrant exploration.
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OBJECTIVES: Inhaled corticosteroids (ICSs) and long-acting beta-agonists (LABAs)
have been recommended for patients with moderate to severe persistent asthma.
This study quantified medication possession ratios (MPRs) for those asthmatic
patients and assessed the association between severe asthma exacerbations (SAEs)
and degree ofmedication compliance.METHODS:The primary data sourcewas the
MarketScan Multistate Medicaid database from 2002 to 2007. A total of 299,917
patients (ages 0-64) with moderate or severe asthma were selected. Drug use was
tracked for ICSs, LABAs, ICS/LABA combination drugs, short-acting beta agonists
leukotriene modifiers, and oral and IV steroids. An ICS-and-LABA MPR was calcu-
lated as the sum of days’ supply for ICS and LABA drugs divided by the number of
follow-up days during the first year after the patient’s asthma index date. Logistic
regressions were used to assess the risk of SAEs associated with degree of medica-
tion compliance. RESULTS: There were 21,852 (7.3%) patients with severe persis-
tent and 278,065 (92.7%) patients with moderate persistent asthma. Within 12
months after asthma index date, averageMPRswere 0.23 (median 0.14) for ICSs and
LABAs and 0.66 (median 0.46) across all asthma medications. After controlling for
covariates like age, gender, race, and comorbidities, the odds ratios of an asthma-
related emergency department (ED) visit was 0.81 (0.79-0.84) for a higher ICS-and-
LABA MPR, but the odds ratio of asthma-related hospitalization or intubation was
1.56 (1.50-1.62). Other key risk factors (p0.0001) included being African American,
having an alcohol/substance abuse disorder, pregnancy, obesity, and upper respi-
ratory tract infection. CONCLUSIONS: A higher ICS-and-LABA MPR appears to be
associated with a lower risk of asthma-related ED visits, but higher risk of asthma-
related hospitalization or intubation. Certain patients with asthma, such as preg-
nant adolescents and African Americans, seem particularly vulnerable to SAEs.
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OBJECTIVES: Sub-optimal beliefs about chronicity of asthma may interfere with
adherence to therapy and result in poor asthma control. Objective of the studywas
to characterize the beliefs about the chronicity of asthma and determine its asso-
ciation with medication adherence and self-management in asthma patients.
METHODS: Adult patients (n166) with previously diagnosed persistent asthma
visiting emergency room (March 2009-December 2009) of a public chest hospital of
Delhi for asthma exacerbation completed interviewer- administered questionnaire
on socio-demographics, clinical history, disease beliefs, use of inhaled corticoste-
roids (ICS), and self-management of asthma after stabilization of their condition.
RESULTS: The cohort had 54% patients in the age group of 30-40 years, 64% fe-
males, 11% illiterate, and 65% patients earning less than INR 10,000/month. Overall
87% patients believed that they had asthma when they are having symptoms,
which is called as no symptoms, no asthma belief. No association was found be-
tween no symptoms, no asthma belief with gender, income, family history of
asthma and co-morbidity. Younger patients in the age group 18-29 years had four
to fivefold greater odds and patients with education above 10th grade had three to
fourfold greater odds of having the no symptoms, no asthma belief or the acute
episodic belief. Acute episodic belief was negatively associated with beliefs about
always having asthma, asthma being a serious condition, having lung inflamma-
tion, or the importance of using ICS, and was positively associated with expecting
to be cured (p0.05). All patients irrespective of their belief of acute or chronic
nature of asthmahad poor adherence to the treatment and other self-management
behaviors. CONCLUSIONS: Majority of the asthma patients believed asthma as
acute episodic disease and had sub-optimal information about asthma. These be-
liefs need to be addressed by providing asthma education leading to medication
adherence and asthma control.
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OBJECTIVES:Non-adherence to a prescribed therapeutic program is an issue in the
treatment of chronic diseases more so for asthma, in which the lack of symptoms
may be interpreted as remission and beliefs about inhaled corticosteroid (ICS)
could also result in non-adherence. The objective of the study was to analyse the
self-reported adherence to ICS therapy and beliefs about medicine. METHODS:
Adult patients previously diagnosed with asthma and who were prescribed ICS,
visiting emergency room of a tertiary care public chest hospital for asthma exac-
erbation were recruited (March 2008-December 2009). Patients completed self-re-
ported questionnaire containing 49 questions on 6 domains: socio-demographic,
clinical profile, causal belief, self-report on adherence, beliefs aboutmedicines and
medication adherence report scale (MARS) after stabilization. RESULTS: Of the 200
patients, 51.5% were between 30-40 years, 64% were female, mean duration of
asthma was 10.58.1 years and 51.5% were having severe asthma. Salient findings
on self-report adherence were, 49% reported that they took ICS even if asymptom-
atic; 91% reported that they forgot to take their ICS some or most of the times; 84%
reported that they avoided ICS some of the times. In response to individual item for
MARS, 15.5% claimed that they took ICS as prescribed. Significant positive correla-
tion was observed between treatment necessity and reported adherence (r0.445,
p 0.001). Patients whowere concerned for the potential effects and risk of depen-
dence had low adherence with significantly negative correlation. Younger age
group had a significant correlation with social inhibition and female gender corre-
lated significantly with fear of adverse effects and social inhibition as the cause for
avoiding ICS. CONCLUSIONS: The findings support the model of treatment adher-
ence, which incorporated beliefs about treatment as well as illness perceptions.
The necessary-concerns offer a potentially useful framework to help clinicians
elicits key treatment beliefs influencing adherence to ICS.
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OBJECTIVES: Asthma is a chronic inflammatory disorder of the airways and the
prevalence of asthma has been increasing since the early 1980 across all age, gen-
der and racial groups. Current asthma treatment guidelines suggest combination
therapy of inhaled corticosteroid(ICS) and long acting beta agonist(LABA) for man-
agement of moderate to severe asthma. The primary objective was to identify
effects of adherence to combination therapy of LABA and ICS(LABAICS) on emer-
gency department(ED) utilization in newly diagnosed asthma patients. The sec-
ondary objective was to identify and use instrumental variables(IVs) to control for
sample selection bias.METHODS: A de-identified patient claims nationwide com-
mercial database was used to identify 7171 patients who were newly diagnosed
with asthma. Patient adherence to LABAICS was measured using Medication
Possession Ratio(MPR) with two years follow-up. IVs including medication copay
and a binary indicator variable for mail prescription order were tested for over-
identification and endogeneity using Sargan test and Hausman specification test.
Differences in ED visit by MPR and adherence group(PoorMPR80%,
GoodMPR80%) were analyzed by Cox proportional hazards model with a linear
transformation. RESULTS: Patients with good adherence were significantly older
than poor adherent patients(52 years vs. 48 years, p0.05) and had significantly
higher proportion of mail prescription order as well as medication copay. Every 1%
increase in MPR was associated with a risk of approximately 4% of having an ED
visit(HR3.72, p0.001) and the risk association for bivariate variable MPR in-
creased from 79% to a two-fold while controlling for gender, age, and comorbidi-
ties(HR2.03, p0.001). Only one instrument of proportion of prescription mail
order was accepted as the valid instrument and the results demonstrated that
every 1% increase in MPR was significantly associated with 4.9% of risk in utilizing
ED while holding other covariates constant(p0.001). CONCLUSIONS:We found a
risk association between high adherence and ED utilization in newly diagnosed
asthma patients with LABAICS.
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OBJECTIVES:Asthma is a prevalent conditionworld-wide, but little is known of the
awareness and impact of the condition among Brazilian adults. The current study
assessed awareness of asthma and whether asthma is associated with decreased
health-related quality of life (HRQoL) among Brazilians aged 18 years and older.
METHODS: Data were taken from the 2011 Brazil National Health and Wellness
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